এই ওষুধে সাশ্রয় করুন
একই সক্রিয় উপাদানের অন্যান্য ব্র্যান্ড
এই ব্র্যান্ডগুলোতে একই সক্রিয় উপাদান আছে (Omeprazole). একই মাত্রা ও ধরন। বদলানোর আগে আপনার ডাক্তার বা ফার্মাসিস্টের সাথে নিশ্চিত হয়ে নিন।
ইঙ্গিত ও ব্যবহার
Glaxizol 20 এর জন্য নির্দেশিত:
ডোজ নির্দেশিকা
শুধুমাত্র নির্দেশিকা তথ্য
প্রদর্শিত ডোজগুলি সরকারি উৎসের সাধারণ নির্দেশিকা। ব্যক্তিগতকৃত ডোজের জন্য সর্বদা আপনার ডাক্তার বা ফার্মাসিস্টের পরামর্শ নিন।
প্রাপ্তবয়স্ক:
Dosage Oral use. For benign gastric and duodenal ulcer, the usual dose is 20 mg once daily, given for 4 weeks in duodenal ulceration and for 8 weeks in gastric ulceration; in severe or recurrent cases the dose may be increased to 40 mg daily. The maintenance dose for recurrent duodenal ulcer is 20 mg once daily, and for prevention of relapse in duodenal ulcer the dose is 10 to 20 mg daily. For NSAID associated duodenal or gastric ulcer, the dose is 20 mg once daily for 4 weeks, continued for a further 4 weeks if not fully healed; 20 mg once daily is also used as prophylaxis in patients with a history of NSAID associated duodenal or gastric ulcers. For gastro esophageal reflux disease, the dose is 20 mg once daily for 4 weeks, continued for a further 4 to 8 weeks if not fully healed; 40 mg once daily has been given for 8 weeks in gastro esophageal reflux disease that is refractory to other treatment, and the maintenance dose is 20 mg once daily. For long term management of acid reflux disease, the dose is 10 to 20 mg daily. For acid related dyspepsia, the dose is 10 to 20 mg once daily for 2 to 4 weeks. For prophylaxis of acid aspiration, 40 mg is given on the preceding evening, then a further 40 mg 2 to 6 hours before surgery. For Zollinger Ellison syndrome (ZES), the initial dose is 60 mg once daily, with a usual range of 20 to 120 mg daily; if the daily dose exceeds 80 mg, it should be given in two divided doses. For Helicobacter pylori eradication in peptic ulcer disease, omeprazole is recommended at a dose of 20 mg twice daily together with antimicrobial agents, using one of the following combinations: amoxicillin 500 mg with metronidazole 400 mg, both three times a day for one week; or clarithromycin 250 mg with metronidazole 400 mg, both twice a day for one week; or amoxicillin 1 g with clarithromycin 500 mg, both twice a day for one week. For paediatric use in severe ulcerating reflux esophagitis in children over 1 year, if body weight is 10 to 20 kg the dose is 10 to 20 mg once daily for 4 to 12 weeks, and if body weight is over 20 kg the dose is 20 to 40 mg once daily for 4 to 12 weeks. Intravenous injection. For prophylaxis of acid aspiration, omeprazole 40 mg is given slowly as an intravenous injection over about 5 minutes, one hour before surgery. For duodenal ulcer, gastric ulcer or reflux oesophagitis in patients for whom oral medication is not suitable, omeprazole 40 mg once daily by IV injection is recommended. For Zollinger Ellison syndrome (ZES), the recommended initial intravenous dose is 60 mg daily; higher daily doses may be needed and should be adjusted individually, and when the daily dose exceeds 60 mg it should be divided and given twice daily.
পার্শ্বপ্রতিক্রিয়া
Omeprol is well tolerated, and the side effects seen so far have generally been mild and reversible. Skin rash, urticaria and pruritus have been reported, and these usually clear up once treatment is stopped. In isolated cases, people have also had photosensitivity, bullous eruption, erythema multiforme, angioedema and alopecia. Diarrhoea and headache have been reported. In a small number of patients they were severe enough that therapy had to be stopped, and in most cases the symptoms went away after that. Other gastrointestinal reactions include constipation, nausea or vomiting, flatulence and abdominal pain. Dry mouth, stomatitis and candidiasis have appeared only as isolated cases. Paraesthesia has also been reported. Dizziness, light headedness and feeling faint have been linked with treatment, but all of these usually settle when therapy is stopped. Somnolence, insomnia and vertigo have been reported too. Reversible mental confusion, agitation, depression and hallucinations have happened mostly in severely ill patients. Arthritic and myalgic symptoms have been reported, and these have usually resolved once therapy was stopped. The following have been reported in isolated cases: blurred vision, taste disturbance, peripheral oedema, increased sweating, gynaecomastia, leucopenia, thrombocytopenia, agranulocytosis, pancytopenia, anaphylactic shock, malaise, fever and bronchospasm. Also reported are encephalopathy in patients who already had severe liver disease, hepatitis with or without jaundice, and, rarely, interstitial nephritis and hepatic failure. Increases in liver enzymes have been observed.
সতর্কতা ও নিষেধাজ্ঞা
সতর্কতা ও সাবধানতা
Don't use clopidogrel and Omeprol together, because clopidogrel doesn't work as well when the two are given at the same time. Observational studies suggest that treatment with a proton pump inhibitor (PPI) may be linked to a higher risk of osteoporosis-related fractures of the hip, wrist or spine. In some patients on long-term Omeprol treatment, atrophic gastritis has occasionally been seen in biopsies taken from the gastric corpus. Using a PPI together with methotrexate may also lead to methotrexate toxicities.
নিষেধাজ্ঞা
যাঁদের Omeprazole-এ অ্যালার্জি বা অতি সংবেদনশীলতা আছে বলে জানা আছে, তাঁদের এই ওষুধ ব্যবহার করা যাবে না। পাকস্থলীতে ঘা (gastric ulcer) হয়েছে বলে সন্দেহ হলে, Omeprazole শুরু করার আগে ক্যান্সার আছে কি না তা নিশ্চিতভাবে বাদ দিতে হবে। কারণ এই ওষুধ উপসর্গ কমিয়ে দিতে পারে এবং ভেতরের ক্যান্সার ঢেকে ফেলতে পারে। এতে রোগ নির্ণয় দেরি হয়ে যেতে পারে।